Build Your Comparison

Side-by-side financial analysis
OMI logo
OMI
MCK logo
MCK
KO logo
KO
CAH logo
CAH
HSIC logo
HSIC
Try popular comparisons:

Stock Comparison

OMI vs MCK vs KO vs CAH vs HSIC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-70.6%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$90.23B
5Y Perf.+441.8%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$341.71B
5Y Perf.+67.4%
CAH
Cardinal Health, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$52.19B
5Y Perf.+311.7%
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$9.17B
5Y Perf.+29.3%

OMI vs MCK vs KO vs CAH vs HSIC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OMI logoOMI
MCK logoMCK
KO logoKO
CAH logoCAH
HSIC logoHSIC
IndustryMedical - DistributionMedical - DistributionBeverages - Non-AlcoholicMedical - DistributionMedical - Distribution
Market Cap$171M$90.23B$341.71B$52.19B$9.17B
Revenue (TTM)$2.76B$403.43B$49.28B$250.55B$13.18B
Net Income (TTM)$-1.10B$4.76B$13.70B$1.56B$398M
Gross Margin3.6%61.7%3.7%29.1%
Operating Margin1.0%1.6%29.3%0.9%5.8%
Forward P/E2.3x17.0x24.3x20.6x14.9x
Total Debt$320M$8.61B$45.49B$9.35B$3.69B
Cash & Equiv.$282M$3.98B$10.27B$3.87B$156M

OMI vs MCK vs KO vs CAH vs HSICLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OMI
MCK
KO
CAH
HSIC
StockJun 20Feb 26Return
Owens & Minor, Inc. (OMI)10029.4-70.6%
McKesson Corporation (MCK)100541.8+441.8%
The Coca-Cola Compa… (KO)100167.4+67.4%
Cardinal Health, In… (CAH)100411.7+311.7%
Henry Schein, Inc. (HSIC)100129.3+29.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: OMI vs MCK vs KO vs CAH vs HSIC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: KO leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Owens & Minor, Inc. is the stronger pick specifically for valuation and capital efficiency. MCK, CAH, and HSIC also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇KO emerged as the overall leader. Track its performance:
OMI
Owens & Minor, Inc.
The Value Play

OMI is the #2 pick in this set and the best alternative if value is your priority.

  • Lower P/E (2.3x vs 14.9x)
Best for: value
MCK
McKesson Corporation
The Growth Play

MCK ranks third and is worth considering specifically for growth exposure and long-term compounding.

  • Rev growth 12.4%, EPS growth 49.2%, 3Y rev CAGR 13.4%
  • 328.4% 10Y total return vs CAH's 215.4%
  • 12.4% revenue growth vs OMI's -74.2%
Best for: growth exposure and long-term compounding
KO
The Coca-Cola Company
The Income Pick

KO carries the broadest edge in this set and is the clearest fit for income & stability and valuation efficiency.

  • Dividend streak 56 yrs, beta -0.23, yield 2.6%
  • PEG 2.17 vs HSIC's 4.74
  • Beta -0.23, yield 2.6%, current ratio 1.46x
  • 27.8% margin vs OMI's -39.8%
Best for: income & stability and valuation efficiency
CAH
Cardinal Health, Inc.
The Momentum Pick

CAH is the clearest fit if your priority is momentum.

  • +35.3% vs OMI's -70.0%
Best for: momentum
HSIC
Henry Schein, Inc.
The Defensive Pick

HSIC is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.63, Low D/E 76.9%, current ratio 1.38x
  • Beta 0.63 vs OMI's 1.41
Best for: sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK12.4% revenue growth vs OMI's -74.2%
ValueOMI logoOMILower P/E (2.3x vs 14.9x)
Quality / MarginsKO logoKO27.8% margin vs OMI's -39.8%
Stability / SafetyHSIC logoHSICBeta 0.63 vs OMI's 1.41
DividendsKO logoKO2.6% yield, 56-year raise streak, vs MCK's 0.4%, (2 stocks pay no dividend)
Momentum (1Y)CAH logoCAH+35.3% vs OMI's -70.0%
Efficiency (ROA)KO logoKO13.1% ROA vs OMI's -44.9%, ROIC 15.8% vs 1.8%

OMI vs MCK vs KO vs CAH vs HSIC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M
MCKMcKesson Corporation
FY 2026
North American Pharmaceutical Segment
83.4%$336.7B
Oncology And Multispecialty Segment
12.0%$48.4B
Medical-Surgical Solutions Segment
2.9%$11.5B
Prescription Technology Solutions Segment
1.4%$5.8B
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
0.3%$1.0B
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B
CAHCardinal Health, Inc.
FY 2025
Pharmaceutical Member
91.9%$204.6B
GMPD
5.7%$12.6B
Other Operating Segment
2.4%$5.4B
HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M

OMI vs MCK vs KO vs CAH vs HSIC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGHSIC

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 5 of 6 comparable metrics.

MCK is the larger business by revenue, generating $403.4B annually — 146.1x OMI's $2.8B. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to OMI's -39.8%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…KO logoKOThe Coca-Cola Com…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
RevenueTrailing 12 months$2.8B$403.4B$49.3B$250.5B$13.2B
EBITDAEarnings before interest/tax$277M$7.1B$15.5B$3.2B$1.1B
Net IncomeAfter-tax profit-$1.1B$4.8B$13.7B$1.6B$398M
Free Cash FlowCash after capex-$353M$5.9B$12.6B$4.4B$561M
Gross MarginGross profit ÷ Revenue+3.6%+61.7%+3.7%+29.1%
Operating MarginEBIT ÷ Revenue+1.0%+1.6%+29.3%+0.9%+5.8%
Net MarginNet income ÷ Revenue-39.8%+1.2%+27.8%+0.6%+3.0%
FCF MarginFCF ÷ Revenue-12.8%+1.5%+25.5%+1.8%+4.3%
Rev. Growth (YoY)Latest quarter vs prior year-146.3%+6.0%+12.1%+11.0%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+4.5%+37.0%+18.2%-19.5%+14.9%
KO leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

OMI leads this category, winning 4 of 7 comparable metrics.

At 19.6x trailing earnings, MCK trades at a 43% valuation discount to CAH's 34.4x P/E. Adjusting for growth (PEG ratio), KO offers better value at 2.34x vs HSIC's 7.75x — a lower PEG means you pay less per unit of expected earnings growth.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…KO logoKOThe Coca-Cola Com…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
Market CapShares × price$171M$90.2B$341.7B$52.2B$9.2B
Enterprise ValueMkt cap + debt − cash$209M$94.9B$376.9B$57.7B$12.7B
Trailing P/EPrice ÷ TTM EPS-0.16x19.56x26.12x34.38x24.44x
Forward P/EPrice ÷ next-FY EPS est.2.31x16.96x24.27x20.60x14.95x
PEG RatioP/E ÷ EPS growth rate2.34x7.75x
EV / EBITDAEnterprise value multiple1.70x13.21x25.45x18.81x11.88x
Price / SalesMarket cap ÷ Revenue0.06x0.22x7.13x0.23x0.70x
Price / BookPrice ÷ Book value/share9.99x2.03x
Price / FCFMarket cap ÷ FCF15.78x64.52x28.21x16.00x
OMI leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — MCK and KO each lead in 3 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-21 for OMI. HSIC carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to KO's 1.33x. On the Piotroski fundamental quality scale (0–9), MCK scores 7/9 vs OMI's 2/9, reflecting strong financial health.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…KO logoKOThe Coca-Cola Com…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
ROE (TTM)Return on equity-21.1%+41.1%+8.2%
ROA (TTM)Return on assets-44.9%+5.7%+13.1%+2.8%+3.6%
ROICReturn on invested capital+1.8%+2.5%+15.8%+33.8%+7.1%
ROCEReturn on capital employed+1.3%+44.8%+17.3%+19.2%+9.8%
Piotroski ScoreFundamental quality 0–927764
Debt / EquityFinancial leverage1.33x0.77x
Net DebtTotal debt minus cash$38M$4.6B$35.2B$5.5B$3.5B
Cash & Equiv.Liquid assets$282M$4.0B$10.3B$3.9B$156M
Total DebtShort + long-term debt$320M$8.6B$45.5B$9.3B$3.7B
Interest CoverageEBIT ÷ Interest expense-0.12x51.78x10.70x6.38x4.59x
Evenly matched — MCK and KO each lead in 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CAH leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CAH five years ago would be worth $41,353 today (with dividends reinvested), compared to $514 for OMI. Over the past 12 months, CAH leads with a +35.3% total return vs OMI's -70.0%. The 3-year compound annual growth rate (CAGR) favors CAH at 35.7% vs OMI's -50.9% — a key indicator of consistent wealth creation.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…KO logoKOThe Coca-Cola Com…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
YTD ReturnYear-to-date-3.4%-8.6%+16.4%+8.3%+4.0%
1-Year ReturnPast 12 months-70.0%+3.4%+17.7%+35.3%+12.4%
3-Year ReturnCumulative with dividends-88.2%+85.0%+39.3%+149.7%+2.6%
5-Year ReturnCumulative with dividends-94.9%+312.8%+65.3%+313.5%+6.5%
10-Year ReturnCumulative with dividends-87.3%+328.4%+115.0%+215.4%+16.6%
CAGR (3Y)Annualised 3-year return-50.9%+22.8%+11.7%+35.7%+0.9%
CAH leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — KO and CAH each lead in 1 of 2 comparable metrics.

KO is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than OMI's 1.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAH currently trades 94.9% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…KO logoKOThe Coca-Cola Com…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
Beta (5Y)Sensitivity to S&P 5001.41x-0.11x-0.23x-0.05x0.63x
52-Week HighHighest price in past year$9.55$999.00$84.04$233.60$89.29
52-Week LowLowest price in past year$1.84$637.00$65.35$137.75$61.95
% of 52W HighCurrent price vs 52-week peak+23.5%+75.1%+94.5%+94.9%+89.5%
RSI (14)Momentum oscillator 0–10046.551.849.275.462.9
Avg Volume (50D)Average daily shares traded690K906K13.6M2.0M1.4M
Evenly matched — KO and CAH each lead in 1 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: OMI as "Hold", MCK as "Buy", KO as "Buy", CAH as "Buy", HSIC as "Buy". Consensus price targets imply 596.4% upside for OMI (target: $16) vs 8.5% for KO (target: $86). For income investors, KO offers the higher dividend yield at 2.56% vs MCK's 0.41%.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…KO logoKOThe Coca-Cola Com…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuyBuy
Price TargetConsensus 12-month target$15.60$994.86$86.13$253.38$87.43
# AnalystsCovering analysts1031483333
Dividend YieldAnnual dividend ÷ price+0.4%+2.6%+0.9%
Dividend StreakConsecutive years of raises01856401
Dividend / ShareAnnual DPS$3.07$2.04$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.3%+0.2%+1.5%+9.3%
KO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

KO leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). OMI leads in 1 (Valuation Metrics). 2 tied.

Best OverallThe Coca-Cola Company (KO)Leads 2 of 6 categories
Loading custom metrics...

OMI vs MCK vs KO vs CAH vs HSIC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is OMI or MCK or KO or CAH or HSIC a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 12.

4% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). McKesson Corporation (MCK) offers the better valuation at 19. 6x trailing P/E (17. 0x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OMI or MCK or KO or CAH or HSIC?

On trailing P/E, McKesson Corporation (MCK) is the cheapest at 19.

6x versus Cardinal Health, Inc. at 34. 4x. On forward P/E, Owens & Minor, Inc. is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Coca-Cola Company wins at 2. 17x versus Henry Schein, Inc. 's 4. 74x.

03

Which is the better long-term investment — OMI or MCK or KO or CAH or HSIC?

Over the past 5 years, Cardinal Health, Inc.

(CAH) delivered a total return of +313. 5%, compared to -94. 9% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: MCK returned +328. 4% versus OMI's -87. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OMI or MCK or KO or CAH or HSIC?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

23β versus Owens & Minor, Inc. 's 1. 41β — meaning OMI is approximately -705% more volatile than KO relative to the S&P 500. On balance sheet safety, Henry Schein, Inc. (HSIC) carries a lower debt/equity ratio of 77% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — OMI or MCK or KO or CAH or HSIC?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 12.

4% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, MCK leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OMI or MCK or KO or CAH or HSIC?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 1. 0% for OMI. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OMI or MCK or KO or CAH or HSIC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, The Coca-Cola Company (KO) is the more undervalued stock at a PEG of 2. 17x versus Henry Schein, Inc. 's 4. 74x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Owens & Minor, Inc. (OMI) trades at 2. 3x forward P/E versus 24. 3x for The Coca-Cola Company — 22. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 596. 4% to $15. 60.

08

Which pays a better dividend — OMI or MCK or KO or CAH or HSIC?

In this comparison, KO (2.

6% yield), CAH (0. 9% yield), MCK (0. 4% yield) pay a dividend. OMI, HSIC do not pay a meaningful dividend and should not be held primarily for income.

09

Is OMI or MCK or KO or CAH or HSIC better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

23), 2. 6% yield, +115. 0% 10Y return). Both have compounded well over 10 years (KO: +115. 0%, OMI: -87. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OMI and MCK and KO and CAH and HSIC?

These companies operate in different sectors (OMI (Healthcare) and MCK (Healthcare) and KO (Consumer Defensive) and CAH (Healthcare) and HSIC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

KO, CAH pay a dividend while OMI, MCK, HSIC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.